The combretazet beta-lactams are cis-restricted analogues of combretastatin A-4, chemically manipulated to enhance their in vitro and in vivo stability. They are extremely potent anti-proliferative agents targeting the colchicine-binding site of tubulin, as microtubule destabilisers leading to G2/M phase arrest, karyorrhexis and ultimately, apoptosis and cell death. 3-Hydroxyl combretazets demonstrate excellent IC50 values in subnanomolar range across a panel of cancer cell lines. We have previously reported chiral diastereomeric resolution of b-lactam racemates using chiral derivatising reagent N-Boc-L-proline to afford enantiopure b-lactams, albeit with large process mass intensities (PMI) of approximately 150,000 kg/kg and modest yields (5-10%), insufficient for progression toward in vivo pre-clinical toxicology studies. The 3S,4S enantiomer was isolated in >90% enantiomeric excess (ee). However, poor diastereomeric excess was obtained for the second eluting 3R,4R diastereomer yielding equally poor ee (50-60%) for its corresponding enantiomer. The process was labour and solvent intensive. Committed to the design of a sustainable, green and safer resolution process, biocatalysis using lipase chemoenzymatic mediated kinetic resolution (KR) toward combretazet enantiomers was investigated.Candida antarctica lipase B (CAL-B) catalysed KR of 3-acetoxy beta-lactams toward their corresponding enantioenriched 3-hydroxyl 3S,4S beta-lactams in 70-80% ee, comparable to values achieved via diastereomeric resolution. PMI was reduced by 1,300-30,000 fold compared to diastereomeric resolution. Candida antarctica KR of combretazet b-lactams is an accessible enantioseparation strategy, reducing environmental impact while overcoming issues associated with poor yield, with KR yielding sufficient quantities of beta-lactam enantiomers for pre-clinical in vivo toxicological evaluation.
Previous Article in event
GCMS Phytochemical Profiling and evaluation of the effect of methanol extract of Anacardium occidentale (cashew) stem bark on antioxidant and liver function markers of hepatotoxic ratsPrevious Article in session
Next Article in event Next Article in session
A biocatalytic approach for kinetic resolution toward enantiopure anti-cancer beta-lactams using Candida antarctica Lipase B
Published: 07 November 2023 by MDPI in 9th International Electronic Conference on Medicinal Chemistry session Novel and Sustainable approaches in Medicinal Chemistry
https://doi.org/10.3390/ECMC2023-15893 (registering DOI)
Keywords: azetindin-2-ones, biocatalysis, beta-lactams, enantiomers, lipase, microtubules, tubulin, green chemistry, bioengineering, enzymes, anti-cancer